Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 15/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13071647 | 0.91 | HTR2C (0.80) | HTR2CLMNACES2 | |
| SCHEMBL3403900 | 0.91 | HTR2C (0.80) | HTR2CLMNACES2 | |
| SCHEMBL13309952 | 0.90 | HTR2C (0.60) | HTR2CLMNASMN1; SMN2CNR1ALDH1A1 | |
| SCHEMBL3405829 | 0.89 | HTR2C (0.57) | HTR2CLMNASMN1; SMN2CNR1ALDH1A1 | |
| SCHEMBL3400300 | 0.88 | HTR2C (0.56) | HTR2CLMNASMN1; SMN2CNR1ALDH1A1 | |
| SCHEMBL3398198 | 0.87 | HTR2C (0.55) | HTR2CLMNASMN1; SMN2CNR1ALDH1A1 | |
| SCHEMBL3400254 | 0.87 | HTR2C (0.55) | HTR2CLMNASMN1; SMN2CNR1ALDH1A1 | |
| SCHEMBL3399581 | 0.86 | HTR2C (0.56) | HTR2CLMNASMN1; SMN2CNR1ALDH1A1 | |
| SCHEMBL3398178 | 0.86 | HTR2C (0.54) | HTR2CLMNASMN1; SMN2CNR1ALDH1A1 | |
| SCHEMBL14545985 | 0.85 | HTR2C (0.54) | HTR2CLMNASMN1; SMN2CNR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728009-B1 | Thiazole amides, imidazole amides and related analogues | NEUROGEN CORPORATION (US) | 2010-06-01 | — | — | US | disclosed |
| US-7728009-B1 | Thiazole amides, imidazole amides and related analogues | NEUROGEN CORPORATION (US) | 2010-06-01 | — | — | US | disclosed |
| US-7728009-B1 | Thiazole amides, imidazole amides and related analogues | NEUROGEN CORPORATION (US) | 2010-06-01 | — | — | US | disclosed |
| WO-2006089076-A9 | THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES | NEUROGEN CORP (US) | 2007-04-26 | — | — | WO | disclosed |